AI is reinventing the way we invent
Drug discovery is a hugely expensive and often frustrating process. Medicinal chemists must guess which compounds might make good medicines, using their knowledge of how a molecule's structure affects its properties. They synthesize and test countless variants, and most are failures. "Coming up with new molecules is still an art, because you have such a huge space of possibilities," says Barzilay. "It takes a long time to find good drug candidates." By speeding up this critical step, deep learning could offer far more opportunities for chemists to pursue, making drug discovery much quicker.
Jul-4-2020, 02:10:43 GMT
- Country:
- Europe > Switzerland (0.04)
- Asia > Singapore (0.04)
- North America
- United States > California (0.04)
- Canada > Ontario
- Toronto (0.16)
- Genre:
- Research Report (0.46)
- Industry:
- Health & Medicine > Pharmaceuticals & Biotechnology (1.00)
- Government (1.00)
- Energy (1.00)
- Technology: